Discover

TPVG
TriplePoint Venture Growth BDC Corp.
5.07
400 x undefined
700 x undefined
bid
ask
+
0.16
3.26%
550 @ 04:01 AM
5.01 -0.06 (1.10%)
Ytd-22.48%
1y-27.88%
4.90
day range
5.10
4.48
52 week range
7.50
Open4.90Prev Close4.91Low4.90High5.10Mkt Cap205.84M
Vol183.03KAvg Vol332.90KEPS1.05P/E4.83Forward P/E5.74
Beta1.80Short Ratio5.43Inst. Own15.63%Dividend1.20Div Yield16.62
Ex Div Date12-13Earning08-0550-d Avg5.38200-d Avg5.711yr Est7.92
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-062024-090.340.350.012.94%
2024-08-072024-060.430.33-0.1-23.26%
2024-05-012024-030.440.41-0.03-6.82%
2024-03-062023-120.490.47-0.02-4.08%
2023-11-012023-090.540.54N/AN/A
2023-08-022023-060.520.530.011.92%
Upgrade / Downgrade
DateFirmActionFromTo
2024-12-05Compass PointUpgradeNeutralNeutral
2024-11-19Wells FargoUpgradeEqual-WeightEqual-Weight
2024-11-07Piper SandlerUpgradeNeutralNeutral
2024-11-07Keefe, Bruyette & WoodsUpgradeUnderperformMarket Perform
2024-10-29Wells FargoUpgradeUnderweightUnderweight
2024-08-09Ladenburg ThalmannDowngradeBuyNeutral
Profile
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Insider Holder
DateNameRelationQuantityDescription
2024-03-11CASSANI STEPHEN A.Director6.20KPurchase
2023-12-17FORNELLI CYNTHIA MDirector8.82KPurchase
2024-03-13PARK KATHERINE J.Director5.00KPurchase
2024-08-12SRIVASTAVA SAJAL KPresident274.94KPurchase
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Invesco Ltd.1.12M8.16M2.79%
2024-09-29Two Sigma Advisers, LP779.69K5.68M1.95%
2024-09-29Two Sigma Investments, LP556.00K4.05M1.39%
2024-09-29Marshall Wace LLP323.64K2.36M0.81%
2024-09-29Ameriprise Financial, Inc.280.24K2.04M0.70%
2024-09-29Legal & General Group PLC261.07K1.90M0.65%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-10-30Invesco ETF Tr-Invesco KBW High Div Yld Financial ETF1.12M8.16M2.79%
2024-07-30ETFis Ser Tr I-Virtus Private Credit Strategy ETF143.49K1.05M0.36%
2024-09-29Blackstone Alternative Multi-Strategy Fund8.60K62.69K0.02%
2024-07-30EA Series Trust-WHITEWOLF Publicly Listed Private Equity ETF480.003.50K0.00%
2024-09-29John Hancock Var Ins Tr-Total Stock Market Index Tr568.004.14K0.00%
Dividend
DividendDate
0.232026-06-16
0.232026-03-17
0.252025-12-16
0.232025-09-16
0.32025-06-16
0.32025-03-17